2010
DOI: 10.4331/wjbc.v1.i2.21
|View full text |Cite
|
Sign up to set email alerts
|

HIV aspartyl protease inhibitors as promising compounds againstCandida albicansAndré Luis Souza dos Santos

Abstract: Cells of Candida albicans (C. albicans ) can invade humans and may lead to mucosal and skin infections or to deep-seated mycoses of almost all inner organs, especially in immunocompromised patients. In this context, both the host immune status and the ability of C. albicans to modulate the expression of its virulence factors are relevant aspects that drive the candidal susceptibility or resistance; in this last case, culminating in the establishment of successful infection known as candidiasis. C. albicans pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
31
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(34 citation statements)
references
References 112 publications
(103 reference statements)
1
31
0
2
Order By: Relevance
“…As previously described [1,6], SAP4-6 strongly impacts full-virulence of C. albicans phenotype in systemic infections. By using the genetic alternations in SAP4-6 we tested whether these aspartic proteases could have an impact on C. albicans' resistance to the tested sulfones.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As previously described [1,6], SAP4-6 strongly impacts full-virulence of C. albicans phenotype in systemic infections. By using the genetic alternations in SAP4-6 we tested whether these aspartic proteases could have an impact on C. albicans' resistance to the tested sulfones.…”
Section: Discussionmentioning
confidence: 99%
“…Thus the inhibition of Saps represents a promising strategy for the design of anti-virulence drugs, especially in view of the alarming rise in life-threatening systemic fungal infections [5,6]. The blockage of C. albicans Saps should inactivate the pathogen and hence attenuate the infection [5,6]. Therefore, potent Sap inhibitors have been proposed as novel antimycotic agents for the treatment of candidiasis [7].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Extracellular proteases of eukaryotic microbial pathogens have received tremendous research interest as potential drug targets for pharmaceutical intervention (Dash et al, 2003;Dos Santos, 2010). Analysis of proteolytic enzymes of pathogenic micro-organisms might lead to the design of inhibitors to control these pathogens (Dos Santos, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…are associated with a high morbidity and mortality (30-80 % of cases) and therefore remain a major problem worldwide. Thus, the pathogenic adaptation of C. albicans has been the topic of extensive investigations (Dos Santos, 2010;Eggimann et al, 2011). Like most pathogens, C. albicans possess a set of attributes that help the fungal cells to escape the host immune responses and cause a successful infection.…”
Section: Introductionmentioning
confidence: 99%